Cara-lin Lonetree

1.0k total citations
9 papers, 565 citations indexed

About

Cara-lin Lonetree is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Cara-lin Lonetree has authored 9 papers receiving a total of 565 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Genetics. Recurrent topics in Cara-lin Lonetree's work include CRISPR and Genetic Engineering (5 papers), CAR-T cell therapy research (4 papers) and Virus-based gene therapy research (3 papers). Cara-lin Lonetree is often cited by papers focused on CRISPR and Genetic Engineering (5 papers), CAR-T cell therapy research (4 papers) and Virus-based gene therapy research (3 papers). Cara-lin Lonetree collaborates with scholars based in United States and Canada. Cara-lin Lonetree's co-authors include Beau R. Webber, Branden A. Smeester, Branden S. Moriarity, Mitchell G. Kluesner, Walker S. Lahr, Emily J. Pomeroy, Mark J. Osborn, Amber McElroy, Nicholas J. Slipek and Matthew J. Johnson and has published in prestigious journals such as Nature Communications, Blood and International Journal of Molecular Sciences.

In The Last Decade

Cara-lin Lonetree

9 papers receiving 554 citations

Peers

Cara-lin Lonetree
Ysbrand Nusse United States
Jian Deng China
Il‐Kyu Choi South Korea
Bruno Sangiorgi Brazil
Emma Haapaniemi Finland
Jean‐Yves Métais United States
Simona Porcellini Italy
Matteo Boretto Belgium
Michael J. Torres United States
Petra Minder United States
Ysbrand Nusse United States
Cara-lin Lonetree
Citations per year, relative to Cara-lin Lonetree Cara-lin Lonetree (= 1×) peers Ysbrand Nusse

Countries citing papers authored by Cara-lin Lonetree

Since Specialization
Citations

This map shows the geographic impact of Cara-lin Lonetree's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cara-lin Lonetree with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cara-lin Lonetree more than expected).

Fields of papers citing papers by Cara-lin Lonetree

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cara-lin Lonetree. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cara-lin Lonetree. The network helps show where Cara-lin Lonetree may publish in the future.

Co-authorship network of co-authors of Cara-lin Lonetree

This figure shows the co-authorship network connecting the top 25 collaborators of Cara-lin Lonetree. A scholar is included among the top collaborators of Cara-lin Lonetree based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cara-lin Lonetree. Cara-lin Lonetree is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Schmiechen, Zoe C., Adam L. Burrack, Nicholas J. Maurice, et al.. (2025). IL-15 Complex Enhances Agonistic Anti-CD40 + Anti-PDL1 by Correcting the T-bet to Tox Ratio in CD8+ T cells Infiltrating Pancreatic Ductal Adenocarcinoma. Cancer Immunology Research. 13(6). 847–866. 2 indexed citations
2.
Laoharawee, Kanut, Matthew J. Johnson, Walker S. Lahr, et al.. (2022). A Pan-RNase Inhibitor Enabling CRISPR-mRNA Platforms for Engineering of Primary Human Monocytes. International Journal of Molecular Sciences. 23(17). 9749–9749. 1 indexed citations
3.
Kluesner, Mitchell G., Walker S. Lahr, Cara-lin Lonetree, et al.. (2021). CRISPR-Cas9 cytidine and adenosine base editing of splice-sites mediates highly-efficient disruption of proteins in primary and immortalized cells. Nature Communications. 12(1). 2437–2437. 74 indexed citations
4.
Pomeroy, Emily J., John Hunzeker, Mitchell G. Kluesner, et al.. (2019). A Genetically Engineered Primary Human Natural Killer Cell Platform for Cancer Immunotherapy. Molecular Therapy. 28(1). 52–63. 139 indexed citations
5.
Webber, Beau R., Cara-lin Lonetree, Mitchell G. Kluesner, et al.. (2019). Highly efficient multiplex human T cell engineering without double-strand breaks using Cas9 base editors. Nature Communications. 10(1). 5222–5222. 155 indexed citations
6.
Webber, Beau R., Cara-lin Lonetree, Miechaleen D. Diers, et al.. (2018). Multiplex Human T Cell Engineering without Double-Strand Break Induction Using the Cas9 Base Editor System. Blood. 132(Supplement 1). 3495–3495. 2 indexed citations
7.
Osborn, Mark J., Cara-lin Lonetree, Beau R. Webber, et al.. (2016). CRISPR/Cas9 Targeted Gene Editing and Cellular Engineering in Fanconi Anemia. Stem Cells and Development. 25(20). 1591–1603. 26 indexed citations
8.
Webber, Beau R., Mark J. Osborn, Amber McElroy, et al.. (2016). CRISPR/Cas9-based genetic correction for recessive dystrophic epidermolysis bullosa. npj Regenerative Medicine. 1(1). 80 indexed citations
9.
Arpke, Robert W., Radbod Darabi, Tara L. Mader, et al.. (2013). A New Immuno-, Dystrophin-Deficient Model, the NSG-mdx 4Cv Mouse, Provides Evidence for Functional Improvement Following Allogeneic Satellite Cell Transplantation. Stem Cells. 31(8). 1611–1620. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ysbrand Nusse Breakdown of academic impact, for papers by Jian Deng Breakdown of academic impact, for papers by Il‐Kyu Choi Breakdown of academic impact, for papers by Bruno Sangiorgi Breakdown of academic impact, for papers by Emma Haapaniemi Breakdown of academic impact, for papers by Jean‐Yves Métais Breakdown of academic impact, for papers by Simona Porcellini Breakdown of academic impact, for papers by Matteo Boretto Breakdown of academic impact, for papers by Michael J. Torres Breakdown of academic impact, for papers by Petra Minder
Rankless by CCL
2026